Why The U.S. Remains The Most Expensive Market For 'Biologic' Drugs In The World
Biologic drugs, often made with the help of living organisms, are especially lucrative because they have scant competition from biosimilars, drugs akin to generics. It's a different story in Europe.
leia mais em NPR
No comments:
Post a Comment